Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Cell Mol Life Sci. 2021 Jun 15;78(15):5789–5805. doi: 10.1007/s00018-021-03877-9

Figure 3. Increased availability of integrin β7 is insufficient to upregulate CD103 expression on Runx3Tg CD4 T cells.

Figure 3.

(A) Surface β7 expression on CD4 and CD8 LN T cells of WT and β7Tg mice. Data are representative (left), and bar graphs show the summary of 5 independent experiments (right) with a total of 5 WT and 5 β7Tg mice.

(B) Surface CD103 expression on CD8 and CD4 LN T cells of WT and β7Tg mice. Data are representative, and bar graphs show the summary of 4 independent experiments with a total of 4 WT and 5 β7Tg mice (CD8) and 4 WT and 4 β7Tg mice (CD4).

(C) Surface CD103 and β7 expression on CD4SP and CD8SP thymocytes (left) and CD4 and CD8 LN T cells (right) of Runx3Tgβ7Tg mice. The results are representative of 2 independent experiments with a total of 2 WT and 2 Runx3Tgβ7Tg mice.